Novozymes A/S B Shs sedol# B79's ticker is and the CUSIP is K7317J133. A total of 2 filers reported holding Novozymes A/S B Shs sedol# B79 in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $201,000 | -17.3% | 3,195 | -23.9% | 0.03% | -23.5% |
| Q2 2020 | $243,000 | +14.6% | 4,200 | -4.0% | 0.03% | +13.3% |
| Q4 2019 | $212,000 | -1.9% | 4,375 | -5.4% | 0.03% | -9.1% |
| Q2 2019 | $216,000 | 0.0% | 4,625 | -1.6% | 0.03% | -5.7% |
| Q1 2019 | $216,000 | +2.4% | 4,700 | 0.0% | 0.04% | -18.6% |
| Q4 2018 | $211,000 | -18.2% | 4,700 | 0.0% | 0.04% | 0.0% |
| Q3 2018 | $258,000 | +18.3% | 4,700 | +9.3% | 0.04% | +7.5% |
| Q2 2018 | $218,000 | -2.7% | 4,300 | 0.0% | 0.04% | -7.0% |
| Q1 2018 | $224,000 | +3.2% | 4,300 | +13.2% | 0.04% | +4.9% |
| Q4 2017 | $217,000 | -45.8% | 3,800 | -54.5% | 0.04% | -61.3% |
| Q4 2015 | $400,000 | +18.3% | 8,355 | +7.7% | 0.11% | +14.0% |
| Q3 2015 | $338,000 | -3.2% | 7,755 | +5.7% | 0.09% | +3.3% |
| Q2 2015 | $349,000 | +10.4% | 7,340 | +6.2% | 0.09% | +8.4% |
| Q1 2015 | $316,000 | +15.8% | 6,910 | +6.2% | 0.08% | +1.2% |
| Q4 2014 | $273,000 | -11.9% | 6,505 | -2.8% | 0.08% | -15.5% |
| Q3 2014 | $310,000 | -0.6% | 6,695 | +7.6% | 0.10% | +2.1% |
| Q2 2014 | $312,000 | – | 6,225 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ZEVIN ASSET MANAGEMENT LLC | 52,228 | $2,951,000 | 0.69% |
| IFP Advisors, Inc | 400 | $23,000 | 0.00% |